Nasdaq Listing

  • 374Water Files Preliminary Proxy for Reverse Stock Split Approval

    374Water (SCWO) seeks shareholder approval for a reverse stock split (1-for-8 to 1-for-20) at a December 15, 2025 meeting. If approved, split-adjusted trading could begin December 26, 2025. The board can abandon the split even after approval. Management cites maintaining its Nasdaq listing and improving financing options. Recent insider purchases, a Minimum Equity Ownership Policy, and $7.0M from an ATM facility extending cash runway into Q2 2026 were also noted. A Q3 2025 results call is scheduled for November 12, 2025.

    2025年11月2日
  • Terra Innovatum and GSR III Acquisition Corp. Shareholders Approve Business Combination, Anticipating $130 Million in Proceeds

    Terra Innovatum’s merger with GSR III Acquisition Corp. has been approved by GSRT shareholders, paving the way for $130 million in funding upon closing. This capital will support licensing, construction of a micro-modular reactor, and commercialization efforts, targeting a Nasdaq listing under “NKLR.” The deal is expected to close soon, pending standard conditions. Terra Innovatum aims to address energy demands with its SOLO™ reactor, with commercial availability projected by 2028, contingent on regulatory approval and execution.

    2025年10月7日
  • Society Pass Inc. (SOPA) Remains Compliant with Nasdaq Listing Rules

    Society Pass (SOPA) announced it has regained compliance with Nasdaq listing standards, specifically Rule 5550(b)(2), by meeting the minimum stockholders’ equity requirement of $2.5 million. Nasdaq confirmed the compliance on September 2, 2025. Maintaining its Nasdaq listing is crucial for SOPA, a Southeast Asian investment firm, as it allows continued access to capital markets and enhances its visibility among investors in the competitive tech landscape. This follows previous scrutiny regarding its listing status.

    2025年9月8日
  • BriaCell Sets Proposed Effective Date for Share Consolidation

    BriaCell Therapeutics (BCTX) announced a 1-for-10 reverse stock split, effective August 25, 2025, to maintain Nasdaq listing compliance. Shareholders receive one new share for every ten held; fractional shares of 0.5 or greater will be rounded up. The company’s convertible securities will be proportionally adjusted. Post-consolidation, BriaCell will continue trading under BCT (TSX) and BCTX (Nasdaq). Registered shareholders will receive transmittal letters with exchange instructions. The reverse split aims to increase the share price and maintain access to capital markets.

    2025年8月21日